OAC
FBIO icon

OMERS Administration Corp’s Fortress Biotech FBIO Stock Holding History

OMERS Administration Corp’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,700
Closed -$65.4K – 1151
2025
Q3 		$65.4K Buy
+17,700
New +$44.8K ﹤0.01% 1080

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

OMERS Administration Corp's FBIO Position: Q4 2025 in Review

OMERS Administration Corp sold out of Fortress Biotech (FBIO) in Q4 2025, closing a stake of 17,700 shares — an estimated $65.4K sold.

OMERS Administration Corp first reported a position in FBIO in Q3 2025 and held it in 1 quarter. The position peaked at $65.4K in Q3 2025. 52 funds tracked by Wall St. Rank hold FBIO as of Q4 2025.

  • OMERS Administration Corp reported no remaining Fortress Biotech position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 17,700 Fortress Biotech shares in Q4 2025, an estimated $65.4K.
  • OMERS Administration Corp first reported a position in Fortress Biotech in Q3 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Fortress Biotech position peaked at $65.4K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.